WO2004022585A1 - 粒子形成能を有するhbvプレコア蛋白質 - Google Patents
粒子形成能を有するhbvプレコア蛋白質 Download PDFInfo
- Publication number
- WO2004022585A1 WO2004022585A1 PCT/JP2003/011389 JP0311389W WO2004022585A1 WO 2004022585 A1 WO2004022585 A1 WO 2004022585A1 JP 0311389 W JP0311389 W JP 0311389W WO 2004022585 A1 WO2004022585 A1 WO 2004022585A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hbv
- antigen
- protein
- core
- precore
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10123—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020057003885A KR101093783B1 (ko) | 2002-09-06 | 2003-09-05 | 입자 형성능이 있는 hbv 프리코어 단백질 |
AT03794268T ATE473997T1 (de) | 2002-09-06 | 2003-09-05 | Zur bildung von partikeln fähiges hbv-precore- protein |
JP2004534181A JP4459054B2 (ja) | 2002-09-06 | 2003-09-05 | 粒子形成能を有するhbvプレコア蛋白質 |
DE60333370T DE60333370D1 (de) | 2002-09-06 | 2003-09-05 | Zur bildung von partikeln fähiges hbv-precore-protein |
AU2003261977A AU2003261977A1 (en) | 2002-09-06 | 2003-09-05 | Hbv precore protein capable of forming particles |
US10/526,744 US7713532B2 (en) | 2002-09-06 | 2003-09-05 | HBV precore protein capable of forming particles |
EP03794268A EP1535927B1 (en) | 2002-09-06 | 2003-09-05 | Hbv precore protein capable of forming particles |
CA2497972A CA2497972C (en) | 2002-09-06 | 2003-09-05 | Hbv precore protein having a particle-forming ability |
TW093101988A TWI330200B (en) | 2003-09-05 | 2004-01-29 | Hbv pre-core pretein having particle-forming ability |
HK06101205.3A HK1081207A1 (en) | 2002-09-06 | 2006-01-26 | Hbv precore protein capable of forming particles |
US12/654,280 US8383333B2 (en) | 2002-09-06 | 2009-12-16 | HBV precore protein capable of forming particles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-261666 | 2002-09-06 | ||
JP2002261666 | 2002-09-06 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10526744 A-371-Of-International | 2003-09-05 | ||
US12/654,280 Division US8383333B2 (en) | 2002-09-06 | 2009-12-16 | HBV precore protein capable of forming particles |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004022585A1 true WO2004022585A1 (ja) | 2004-03-18 |
Family
ID=31973137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/011389 WO2004022585A1 (ja) | 2002-09-06 | 2003-09-05 | 粒子形成能を有するhbvプレコア蛋白質 |
Country Status (12)
Country | Link |
---|---|
US (2) | US7713532B2 (ja) |
EP (1) | EP1535927B1 (ja) |
JP (1) | JP4459054B2 (ja) |
KR (1) | KR101093783B1 (ja) |
CN (1) | CN100547001C (ja) |
AT (1) | ATE473997T1 (ja) |
AU (1) | AU2003261977A1 (ja) |
CA (1) | CA2497972C (ja) |
DE (1) | DE60333370D1 (ja) |
ES (1) | ES2344737T3 (ja) |
HK (1) | HK1081207A1 (ja) |
WO (1) | WO2004022585A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005111620A1 (ja) | 2004-05-19 | 2005-11-24 | Advanced Life Science Institute, Inc. | B型肝炎ウィルスの検出方法 |
JP2007538232A (ja) * | 2004-05-19 | 2007-12-27 | メルボルン ヘルス | B型肝炎のための治療薬、予防薬、および診断薬 |
JP5332011B2 (ja) * | 2006-10-30 | 2013-11-06 | 株式会社先端生命科学研究所 | B型肝炎ウイルスの高感度免疫学的分析方法及び免疫学的分析用試薬 |
WO2015133613A1 (ja) * | 2014-03-07 | 2015-09-11 | 雅史 溝上 | B型肝炎ウイルスレポーターベクター、b型肝炎ウイルス様粒子及びそれを用いたb型肝炎治療薬のスクリーニング方法 |
WO2020255425A1 (ja) * | 2019-06-21 | 2020-12-24 | 国立研究開発法人理化学研究所 | 抗hbv剤 |
JP7072213B2 (ja) | 2017-12-21 | 2022-05-20 | 国立研究開発法人理化学研究所 | B型肝炎抗原タンパク質を標的としたイメージング用petプローブ |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4386660B2 (ja) * | 2003-03-25 | 2009-12-16 | 株式会社先端生命科学研究所 | Hbv−rnaを含むhbv粒子 |
KR100836745B1 (ko) * | 2007-01-31 | 2008-06-10 | (주)두비엘 | Hbv 백신 및 그의 제조 방법 |
CN103217533B (zh) | 2012-01-21 | 2016-01-06 | 厦门大学 | Anti-HBc定量检测方法及其在监控慢性乙肝患者病情发展和预测治疗疗效中的用途 |
CA2936092A1 (en) | 2013-01-23 | 2014-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Stabilized hepatitis b core polypeptide |
CN113322302B (zh) * | 2021-06-02 | 2023-08-11 | 重庆医科大学 | 一种hbv完整病毒颗粒的免疫捕获分子检测方法 |
CN113777329B (zh) * | 2021-09-16 | 2023-07-18 | 何秋富 | 一种视黄醇结合蛋白测定试剂盒及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001040279A2 (en) * | 1999-12-03 | 2001-06-07 | Innogenetics N.V. | Hbv sequences |
WO2002014871A1 (fr) * | 2000-08-11 | 2002-02-21 | Advanced Life Science Institute, Inc. | Procede servant a detecter ou a determiner vbh |
-
2003
- 2003-09-05 CA CA2497972A patent/CA2497972C/en not_active Expired - Lifetime
- 2003-09-05 US US10/526,744 patent/US7713532B2/en active Active
- 2003-09-05 KR KR1020057003885A patent/KR101093783B1/ko active IP Right Grant
- 2003-09-05 AT AT03794268T patent/ATE473997T1/de not_active IP Right Cessation
- 2003-09-05 WO PCT/JP2003/011389 patent/WO2004022585A1/ja active Application Filing
- 2003-09-05 CN CNB038246767A patent/CN100547001C/zh not_active Expired - Lifetime
- 2003-09-05 EP EP03794268A patent/EP1535927B1/en not_active Expired - Lifetime
- 2003-09-05 DE DE60333370T patent/DE60333370D1/de not_active Expired - Lifetime
- 2003-09-05 JP JP2004534181A patent/JP4459054B2/ja not_active Expired - Lifetime
- 2003-09-05 AU AU2003261977A patent/AU2003261977A1/en not_active Abandoned
- 2003-09-05 ES ES03794268T patent/ES2344737T3/es not_active Expired - Lifetime
-
2006
- 2006-01-26 HK HK06101205.3A patent/HK1081207A1/xx not_active IP Right Cessation
-
2009
- 2009-12-16 US US12/654,280 patent/US8383333B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001040279A2 (en) * | 1999-12-03 | 2001-06-07 | Innogenetics N.V. | Hbv sequences |
WO2002014871A1 (fr) * | 2000-08-11 | 2002-02-21 | Advanced Life Science Institute, Inc. | Procede servant a detecter ou a determiner vbh |
Non-Patent Citations (4)
Title |
---|
KIMURA T. ET AL.: "Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load", J. CLIN. MICROBIOL., vol. 40, no. 2, February 2002 (2002-02-01), pages 439 - 445, XP002973925 * |
SAKAMOTO Y. ET AL.: "Full and empty particles of hepatitis B virus in hepatocytes from patients with HBsAg-positive chronic active hepatitis", LAB. INVEST., vol. 48, no. 6, 1983, pages 678 - 682, XP002973927 * |
TAKAHASHI K. ET AL.: "Molecular heterogeneity of e antigen polypeptides in sera from carriers of hepatitis B virus", J. IMMUNOL., vol. 147, no. 9, 1991, pages 3156 - 3160, XP002973926 * |
TERRE S. ET AL.: "Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo", J. VIROL., vol. 65, no. 10, 1991, pages 5539 - 5543, XP000614617 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005111620A1 (ja) | 2004-05-19 | 2005-11-24 | Advanced Life Science Institute, Inc. | B型肝炎ウィルスの検出方法 |
EP1752768A1 (en) * | 2004-05-19 | 2007-02-14 | Advanced Life Science Institute, Inc. | Method of detecting hepatitis b virus |
EP1752768A4 (en) * | 2004-05-19 | 2007-11-28 | Advanced Life Science Inst Inc | METHOD FOR DETECTING HEPATITIS B VIRUS |
JP2007538232A (ja) * | 2004-05-19 | 2007-12-27 | メルボルン ヘルス | B型肝炎のための治療薬、予防薬、および診断薬 |
JP5332011B2 (ja) * | 2006-10-30 | 2013-11-06 | 株式会社先端生命科学研究所 | B型肝炎ウイルスの高感度免疫学的分析方法及び免疫学的分析用試薬 |
WO2015133613A1 (ja) * | 2014-03-07 | 2015-09-11 | 雅史 溝上 | B型肝炎ウイルスレポーターベクター、b型肝炎ウイルス様粒子及びそれを用いたb型肝炎治療薬のスクリーニング方法 |
JP7072213B2 (ja) | 2017-12-21 | 2022-05-20 | 国立研究開発法人理化学研究所 | B型肝炎抗原タンパク質を標的としたイメージング用petプローブ |
WO2020255425A1 (ja) * | 2019-06-21 | 2020-12-24 | 国立研究開発法人理化学研究所 | 抗hbv剤 |
Also Published As
Publication number | Publication date |
---|---|
HK1081207A1 (en) | 2006-05-12 |
JPWO2004022585A1 (ja) | 2005-12-22 |
EP1535927A4 (en) | 2006-06-21 |
AU2003261977A1 (en) | 2004-03-29 |
CA2497972A1 (en) | 2004-03-18 |
EP1535927A1 (en) | 2005-06-01 |
EP1535927B1 (en) | 2010-07-14 |
US20060166187A1 (en) | 2006-07-27 |
CA2497972C (en) | 2016-04-26 |
US8383333B2 (en) | 2013-02-26 |
DE60333370D1 (de) | 2010-08-26 |
US7713532B2 (en) | 2010-05-11 |
KR20050053636A (ko) | 2005-06-08 |
ATE473997T1 (de) | 2010-07-15 |
US20100285444A1 (en) | 2010-11-11 |
CN1694898A (zh) | 2005-11-09 |
ES2344737T3 (es) | 2010-09-06 |
CN100547001C (zh) | 2009-10-07 |
KR101093783B1 (ko) | 2011-12-19 |
JP4459054B2 (ja) | 2010-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8383333B2 (en) | HBV precore protein capable of forming particles | |
Bremer et al. | N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus | |
Hollinger | Hepatitis B virus genetic diversity and its impact on diagnostic assays | |
JP5836569B2 (ja) | Hcv抗原抗体組み合わせアッセイ用の試薬 | |
JP2778886B2 (ja) | C型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット | |
Pastor et al. | Direct interaction between the hepatitis B virus core and envelope proteins analyzed in a cellular context | |
Hong et al. | Characterization and application of precore/core‐related antigens in animal models of hepatitis B virus infection | |
Mehdi et al. | An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently | |
Feitelson et al. | X antigen/antibody markers in hepadnavirus infections: presence and significance of hepadnavirus X gene product (s) in serum | |
JP2818755B2 (ja) | 非a非b型肝炎の診断及び検出に有効な新規分枝ハイブリッド及びクラスターペプチド | |
EP2794638B1 (fr) | Procede de detection d'une infection par le virus de l'hepatite c | |
Horiike et al. | Characteristics of hepatitis BX antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection | |
TWI330200B (en) | Hbv pre-core pretein having particle-forming ability | |
JP4283527B2 (ja) | Hcvコア・タンパク質配列 | |
Hasmoni et al. | Detection and precipitation of hepatitis B core antigen using a fusion bacteriophage | |
US8076085B2 (en) | Methods and means relating to hepatitis B infection | |
Wei et al. | Development of the diagnostic immunoassay to detect anti-PreS1 (21-47aa) antibody—a marker suggesting the health improvement of hepatitis B patients | |
US20130280821A1 (en) | Method for detecting an infection by hepatitis b virus | |
AU2004290800B2 (en) | Methods and means relating to hepatitis B infection | |
Dawson et al. | Recombinant antigens and synthetic peptides for serodiagnosis of hepatitis E virus infection | |
JPH06153959A (ja) | C型肝炎ウィルスの非構造タンパク質及びそれを用いての診断方法及びキット | |
WO1994011737A1 (en) | Method for detection of a new marker associated with hepatitis delta virus infection | |
JPH02503511A (ja) | 肝炎b型ウイルスと類似のウイルス、その成分並びにワクチンもしくは診断用試薬としての使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004534181 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057003885 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2497972 Country of ref document: CA Ref document number: 2003794268 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006166187 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10526744 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038246767 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2003794268 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057003885 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10526744 Country of ref document: US |